Royalty Pharma (RPD) Q2 2025 Earnings Report
DE:RPD Q2 2025 EPS Results
- Actual EPS
- EUR 1.02
- Consensus EPS
- EUR 0.92
- Beat/Miss
- Beat by +EUR 0.10
- One Year Ago EPS
- EUR 0.86
DE:RPD Q2 2025 Revenue Results
- Actual Revenue
- EUR 518.14M
- Expected Revenue
- EUR 602.59M
- Beat/Miss
- Missed by -EUR 84.46M
- YoY Revenue Growth
- +7.71%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/06/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 6, 2025
DE:RPD Upcoming Earnings
Royalty Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:RPD Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RPD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 1.06- | 1.05 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 1.141.18 | 1.02 | 15.78% (+0.16) | |
| May 06, 2026 | 2026 (Q1) | 1.091.16 | 0.67 | 73.03% (+0.49) | |
| Feb 11, 2026 | 2025 (Q4) | 1.151.31 | 1.03 | 27.37% (+0.28) | |
| Nov 05, 2025 | 2025 (Q3) | 0.891.05 | 0.82 | 27.92% (+0.23) | |
| Aug 06, 2025 | 2025 (Q2) | 0.921.02 | 0.86 | 18.73% (+0.16) | |
| May 08, 2025 | 2025 (Q1) | 0.850.67 | 0.88 | -23.42% (-0.21) | |
| Feb 11, 2025 | 2024 (Q4) | 0.941.03 | 1.03 | 0.17% (+0.00) | |
| Nov 06, 2024 | 2024 (Q3) | 0.830.82 | 0.71 | 16.22% (+0.11) | |
| Aug 08, 2024 | 2024 (Q2) | 0.860.86 | 0.76 | 13.73% (+0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
